Treatment of Bacterial Vaginosis (Gardnerella vaginalis)
For symptomatic non-pregnant women, treat with metronidazole 500 mg orally twice daily for 7 days, which achieves a 95% cure rate and is the CDC's first-line recommendation. 1
Diagnosis Before Treatment
Bacterial vaginosis requires at least 3 of the following 4 Amsel criteria for diagnosis: 1
- Homogeneous white non-inflammatory vaginal discharge
- Clue cells on microscopic examination
- Vaginal pH >4.5
- Positive "whiff test" (fishy odor with 10% KOH)
Alternatively, a Gram stain showing Nugent score ≥4 confirms the diagnosis. 2 Culture of G. vaginalis is not recommended as it lacks specificity. 3
First-Line Treatment Regimens for Non-Pregnant Women
Recommended options (all equally effective): 4, 1
- Metronidazole 500 mg orally twice daily for 7 days - 95% cure rate, most studied regimen 1
- Metronidazole gel 0.75%, one full applicator (5g) intravaginally twice daily for 5 days - 75-84% cure rate 4, 1
- Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days - 78-84% cure rate 4, 1
Alternative Regimens (Lower Efficacy)
Use only when first-line options are not feasible: 4, 1
- Metronidazole 2g orally as single dose - 84% cure rate (lower than 7-day regimen, should not be first-line) 4, 1
- Clindamycin 300 mg orally twice daily for 7 days 4, 1
- Tinidazole 2g once daily for 2 days OR 1g once daily for 5 days - demonstrated superior efficacy over placebo 2
Treatment in Pregnancy
All symptomatic pregnant women require treatment due to associations with preterm birth, premature rupture of membranes, preterm labor, and postpartum endometritis. 5, 1
Preferred regimens for pregnant women (systemic therapy required): 5
- Metronidazole 250 mg orally three times daily for 7 days (CDC first-line) 5
- Clindamycin 300 mg orally twice daily for 7 days (alternative first-line) 5
High-risk pregnant women (history of prior preterm delivery) with asymptomatic BV may be evaluated for treatment, as this has reduced preterm delivery in 3 of 4 randomized trials. 5 Optimal screening time is second trimester (13-24 weeks). 6
Average-risk pregnant women should NOT be routinely screened or treated if asymptomatic, as it does not improve outcomes. 6
Special Clinical Situations Requiring Treatment of Asymptomatic BV
Treatment of asymptomatic BV is indicated before: 6, 1
- Surgical abortion - reduces post-abortion PID substantially 6, 1
- Hysterectomy - reduces postoperative infectious complications by 10-75% 1
- Other invasive gynecological procedures (endometrial biopsy, IUD placement, cesarean section) due to risk of endometritis, PID, and vaginal cuff cellulitis 6
Critical Safety Warnings
Metronidazole precautions: 4, 5, 1
- Patients MUST avoid alcohol during treatment and for 24 hours after completion due to disulfiram-like reaction
Clindamycin cream precautions: 4, 1
- Oil-based formulation may weaken latex condoms and diaphragms
Recurrent Bacterial Vaginosis
50-80% of women experience recurrence within 1 year of treatment. 7, 8
For recurrent BV, use extended therapy: 7
- Metronidazole 500 mg orally twice daily for 10-14 days (first approach)
- If ineffective: Metronidazole gel 0.75% for 10 days, then twice weekly for 3-6 months as suppressive therapy 7
Follow-Up Recommendations
- Non-pregnant women: No follow-up needed if symptoms resolve 1
- Pregnant women (especially high-risk): Follow-up evaluation 1 month after treatment completion to verify cure 6, 5
What NOT to Do
Do NOT treat male sex partners - multiple randomized trials demonstrate this does not prevent recurrence or alter clinical outcomes. 3, 1, 9 Treatment of male partners has shown no benefit in preventing BV recurrence. 3